Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types.
Brain cell-types
Pharmacotherapy
Psychiatric disorders
Journal
Discover mental health
ISSN: 2731-4383
Titre abrégé: Discov Ment Health
Pays: Switzerland
ID NLM: 9918350483906676
Informations de publication
Date de publication:
05 Jan 2023
05 Jan 2023
Historique:
received:
27
11
2022
accepted:
21
12
2022
medline:
20
10
2023
pubmed:
20
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
Pharmacotherapy for most psychiatric conditions was developed from serendipitous observations of benefit from drugs prescribed for different reasons. An algorithmic approach to formulating pharmacotherapy is proposed, based upon which combination of changed activities by brain cell-types is dominant for any particular condition, because those cell-types contain and surrogate for genetic, metabolic and environmental information, that has affected their function. The algorithm performs because functions of some or all the affected cell-types benefit from several available drugs: clemastine, dantrolene, erythropoietin, fingolimod, fluoxetine, lithium, memantine, minocycline, pioglitazone, piracetam, and riluzole PROCEDURES/FINDINGS: Bipolar disorder, major depressive disorder, schizophrenia, Alzheimer's disease, and post-traumatic stress disorder, illustrate the algorithm; for them, literature reviews show that no single combination of altered cell-types accounts for all cases; but they identify, for each condition, which combination occurs most frequently, i.e., dominates, as compared with other possible combinations. Knowing the dominant combination of altered cell-types in a particular condition, permits formulation of therapy with combinations of drugs taken from the above list. The percentage of patients who might benefit from that therapy, depends upon the frequency with which the dominant combination occurs in patients with that particular condition. Knowing the dominant combination of changed cell types in psychiatric conditions, permits an algorithmically formulated, rationally-based treatment. Different studies of the same condition often produce discrepant results; all might be correct, because identical clinical phenotypes result from different combinations of impaired cell-types, thus producing different results. Clinical trials would validate both the proposed concept and choice of drugs.
Sections du résumé
BACKGROUND
BACKGROUND
Pharmacotherapy for most psychiatric conditions was developed from serendipitous observations of benefit from drugs prescribed for different reasons. An algorithmic approach to formulating pharmacotherapy is proposed, based upon which combination of changed activities by brain cell-types is dominant for any particular condition, because those cell-types contain and surrogate for genetic, metabolic and environmental information, that has affected their function. The algorithm performs because functions of some or all the affected cell-types benefit from several available drugs: clemastine, dantrolene, erythropoietin, fingolimod, fluoxetine, lithium, memantine, minocycline, pioglitazone, piracetam, and riluzole PROCEDURES/FINDINGS: Bipolar disorder, major depressive disorder, schizophrenia, Alzheimer's disease, and post-traumatic stress disorder, illustrate the algorithm; for them, literature reviews show that no single combination of altered cell-types accounts for all cases; but they identify, for each condition, which combination occurs most frequently, i.e., dominates, as compared with other possible combinations. Knowing the dominant combination of altered cell-types in a particular condition, permits formulation of therapy with combinations of drugs taken from the above list. The percentage of patients who might benefit from that therapy, depends upon the frequency with which the dominant combination occurs in patients with that particular condition.
CONCLUSIONS
CONCLUSIONS
Knowing the dominant combination of changed cell types in psychiatric conditions, permits an algorithmically formulated, rationally-based treatment. Different studies of the same condition often produce discrepant results; all might be correct, because identical clinical phenotypes result from different combinations of impaired cell-types, thus producing different results. Clinical trials would validate both the proposed concept and choice of drugs.
Identifiants
pubmed: 37861813
doi: 10.1007/s44192-022-00029-8
pii: 10.1007/s44192-022-00029-8
pmc: PMC10501034
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
3Informations de copyright
© 2023. The Author(s).
Références
Neurosci Lett. 2011 Jul 25;499(3):143-8
pubmed: 21669255
Synapse. 2009 Apr;63(4):359-64
pubmed: 19140168
Neurosci Lett. 1993 Aug 6;158(1):105-8
pubmed: 8233063
Neurol Res. 2009 Jun;31(5):496-502
pubmed: 19099671
Acta Neuropathol. 2001 Oct;102(4):373-9
pubmed: 11603813
Rev Neurol. 2014 Aug 1;59(3):121-8
pubmed: 25030072
Hum Mol Genet. 2007 Jun 1;16(11):1307-18
pubmed: 17428816
Br J Pharmacol. 2012 Feb;165(4):861-9
pubmed: 21740406
Cell Death Dis. 2019 Aug 2;10(8):577
pubmed: 31371719
Nature. 2022 Nov;611(7936):532-539
pubmed: 36323788
Arch Gen Psychiatry. 2011 Apr;68(4):340-50
pubmed: 21135314
Neurol Sci. 2015 Sep;36(9):1633-41
pubmed: 25899425
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):707-16
pubmed: 18936150
Nat Neurosci. 2021 Feb;24(2):276-287
pubmed: 33432193
Cell Mol Neurobiol. 2014 May;34(4):539-47
pubmed: 24570112
Bipolar Disord. 2009 Aug;11(5):515-22
pubmed: 19624390
Mol Psychiatry. 2005 Mar;10(3):309-22
pubmed: 15303102
Transl Psychiatry. 2019 Sep 2;9(1):211
pubmed: 31477687
Neurosci Lett. 2020 Apr 1;723:134829
pubmed: 32057920
Mol Pain. 2016 Nov 15;12:
pubmed: 27852966
J Neurosci Res. 2003 Jun 15;72(6):747-55
pubmed: 12774315
Mol Psychiatry. 2022 Feb;27(2):947-955
pubmed: 34719691
Neurocrit Care. 2009;10(1):103-15
pubmed: 18696266
Neuropsychopharmacology. 2007 Jul;32(7):1490-503
pubmed: 17164819
Front Neuroanat. 2018 Feb 14;12:8
pubmed: 29497365
J Neurotrauma. 2015 May 1;32(9):633-44
pubmed: 25366938
Neurotoxicology. 2020 Jan;76:1-9
pubmed: 31593710
J Neurophysiol. 2018 Sep 1;120(3):1307-1317
pubmed: 29790836
Arch Dermatol. 1996 Aug;132(8):934-9
pubmed: 8712844
ACS Chem Neurosci. 2014 Jun 18;5(6):451-8
pubmed: 24803181
Neuron. 2008 Sep 25;59(6):932-46
pubmed: 18817732
EBioMedicine. 2018 Jun;32:72-83
pubmed: 29887330
Mol Pharmacol. 2009 May;75(5):1021-30
pubmed: 19188338
Brain. 1975 Mar;98(1):81-90
pubmed: 123474
J Neurosci. 2007 Jul 18;27(29):7751-61
pubmed: 17634369
Nat Commun. 2020 Mar 9;11(1):1313
pubmed: 32152318
Br J Pharmacol. 2003 Dec;140(7):1313-9
pubmed: 14645141
Cell Death Dis. 2018 Jan 8;9(1):7
pubmed: 29311672
Brain Behav Immun. 2019 Aug;80:889-899
pubmed: 31158497
Int J Mol Sci. 2022 Jun 28;23(13):
pubmed: 35806185
Neuron. 2018 Jun 27;98(6):1141-1154.e7
pubmed: 29861287
Neuron. 2021 Jul 21;109(14):2292-2307.e5
pubmed: 34102111
Am J Psychiatry. 2006 Feb;163(2):257-64
pubmed: 16449479
Am J Pathol. 2010 Jun;176(6):2682-94
pubmed: 20413685
J Mol Neurosci. 2004;24(2):207-16
pubmed: 15456934
Sci Rep. 2021 Mar 2;11(1):4952
pubmed: 33654147
J Neuroimmunol. 2013 Mar 15;256(1-2):13-8
pubmed: 23290828
BMC Biol. 2008 Sep 09;6:37
pubmed: 18782446
Neurosci Res. 2002 Dec;44(4):391-403
pubmed: 12445627
Arch Gen Psychiatry. 2001 Jun;58(6):545-53
pubmed: 11386983
Cell Mol Neurobiol. 2007 May;27(3):351-8
pubmed: 17235693
J Cell Mol Med. 2012 Nov;16(11):2736-44
pubmed: 22697296
J Neurochem. 2006 Jun;97(6):1611-26
pubmed: 16805772
Biol Psychiatry. 1998 Jul 15;44(2):88-97
pubmed: 9646890
J Mol Neurosci. 2017 May;62(1):123-129
pubmed: 28429235
J Cereb Blood Flow Metab. 2012 Mar;32(3):425-36
pubmed: 22234334
Science. 2012 Sep 14;337(6100):1357-60
pubmed: 22984073
J Toxicol Clin Toxicol. 1993;31(4):603-30
pubmed: 8254702
Neuroscience. 1999;92(2):499-513
pubmed: 10408600
Neuropharmacology. 2014 Apr;79:161-71
pubmed: 24316161
Psychopharmacology (Berl). 2011 Jul;216(1):75-84
pubmed: 21301813
Pharmacol Res. 2013 Jan;67(1):1-9
pubmed: 23073075
Biol Psychiatry. 2009 Sep 1;66(5):486-93
pubmed: 19559403
Mol Cell Neurosci. 2013 Sep;56:365-74
pubmed: 23876875
Front Aging Neurosci. 2021 Jan 13;12:627362
pubmed: 33519426
Brain Neurosci Adv. 2021 Apr 27;5:23982128211009148
pubmed: 33997293
Front Pharmacol. 2021 Aug 23;12:738590
pubmed: 34497527
Alcohol Clin Exp Res. 1991 Oct;15(5):834-8
pubmed: 1755517
Oncotarget. 2017 Apr 25;8(17):27676-27692
pubmed: 28430602
Neurosci Biobehav Rev. 2019 Aug;103:150-162
pubmed: 31163205
Biol Psychiatry. 2018 Dec 1;84(11):787-796
pubmed: 30177255
Cell Death Differ. 2013 Feb;20(2):353-65
pubmed: 23138851
PPAR Res. 2017;2017:4089214
pubmed: 28356907
Bipolar Disord. 2019 Mar;21(2):124-131
pubmed: 30422372
Biol Psychiatry. 2003 Jun 15;53(12):1075-85
pubmed: 12814859
Neurobiol Dis. 2014 Nov;71:280-91
pubmed: 25134730
Mol Neurobiol. 2022 Mar;59(3):1665-1692
pubmed: 35013935
J Neurochem. 2015 May;133(4):532-43
pubmed: 25382136
Schizophr Res. 2022 May;243:154-162
pubmed: 35344853
Lancet. 2017 Dec 2;390(10111):2481-2489
pubmed: 29029896
Neuroscience. 2012 Sep 27;221:214-24
pubmed: 22742905
J Affect Disord. 2021 Dec 1;295:513-521
pubmed: 34509066
PLoS One. 2010 Nov 08;5(11):e15430
pubmed: 21151481
J Biol Chem. 2004 Mar 5;279(10):8976-85
pubmed: 14699130
Eur J Neurosci. 2000 Jul;12(7):2215-23
pubmed: 10947800
CNS Drugs. 2009;23(5):397-418
pubmed: 19453201
PLoS One. 2010 Dec 20;5(12):e14382
pubmed: 21187954
Brain Res. 2019 Oct 1;1720:146294
pubmed: 31201815
Biol Psychiatry. 2007 Mar 1;61(5):640-52
pubmed: 16950219
Front Neurosci. 2015 Jan 14;8:457
pubmed: 25642163
Neuron. 2021 May 19;109(10):1657-1674.e7
pubmed: 33831349
Brain Res Bull. 2020 Oct;163:95-108
pubmed: 32730865
Eur J Neurosci. 2012 Jun;35(12):1917-37
pubmed: 22708603
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):336-9
pubmed: 17884273
J Neuroinflammation. 2012 Apr 05;9:63
pubmed: 22480361
J Neurochem. 2000 Oct;75(4):1729-34
pubmed: 10987856
Arzneimittelforschung. 1995 Jan;45(1):1-5
pubmed: 7893259
Biochem Pharmacol. 2008 Feb 15;75(4):956-64
pubmed: 18053965
Neuroreport. 1998 Jun 1;9(8):1757-61
pubmed: 9665596
Transl Oncol. 2020 Feb;13(2):471-480
pubmed: 31918212
Acta Neuropathol. 2012 Sep;124(3):397-410
pubmed: 22810490
J Neurosci. 2008 Sep 17;28(38):9473-85
pubmed: 18799679
PLoS One. 2020 May 13;15(5):e0232855
pubmed: 32401791
Cell. 2016 Mar 24;165(1):207-219
pubmed: 26949184
Biol Psychiatry. 2000 Oct 15;48(8):766-77
pubmed: 11063973
Alcohol. 1995 May-Jun;12(3):279-88
pubmed: 7639963
J Neurosci. 2013 May 8;33(19):8454-62
pubmed: 23658182
Am J Alzheimers Dis Other Demen. 2017 May;32(3):166-181
pubmed: 28423937
Stroke. 2017 Dec;48(12):3336-3346
pubmed: 29114096
Mol Psychiatry. 2022 Sep;27(9):3708-3718
pubmed: 35705634
Int J Mol Sci. 2020 Apr 27;21(9):
pubmed: 32349283
J Psychiatr Res. 2015 Jun;65:53-62
pubmed: 25930075
Nat Neurosci. 2012 Dec;15(12):1621-3
pubmed: 23143512
Neuroscience. 2005;133(4):959-67
pubmed: 15964487
Acta Neuropathol. 2013 Jul;126(1):75-91
pubmed: 23512378
J Neurosci Res. 2012 May;90(5):933-44
pubmed: 22253205
J Cell Biol. 2018 Feb 5;217(2):459-472
pubmed: 29196460
Biol Psychiatry. 2008 Nov 15;64(10):863-70
pubmed: 18639237
Neural Plast. 2016;2016:8075903
pubmed: 27747106
J Neurochem. 2003 May;85(4):872-81
pubmed: 12716419
PLoS Biol. 2019 Jun 21;17(6):e3000330
pubmed: 31226122
Adv Clin Exp Med. 2019 Dec;28(12):1697-1704
pubmed: 31851793
Nucleic Acids Res. 2011 Mar;39(4):e24
pubmed: 21112872
Science. 2019 Apr 12;364(6436):
pubmed: 30975859
Biol Psychiatry. 2002 Oct 1;52(7):708-15
pubmed: 12372661
Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):401-12
pubmed: 16080015
PLoS One. 2012;7(11):e50500
pubmed: 23185633
Front Cell Neurosci. 2016 Feb 02;10:8
pubmed: 26869881
Cereb Cortex. 2002 Apr;12(4):386-94
pubmed: 11884354
Dev Neurobiol. 2018 Feb;78(2):152-162
pubmed: 28884925
Mol Psychiatry. 2022 Jul 20;:
pubmed: 35854107
J Psychiatry Neurosci. 2013 Jul;38(4):276-84
pubmed: 23415275
Sci Rep. 2017 Jan 30;7:41734
pubmed: 28134307
Neurotoxicology. 2002 May;23(1):19-31
pubmed: 12164545
Cell Physiol Biochem. 2016;38(2):714-25
pubmed: 26870942
Neurosci Lett. 1997 Oct 3;234(2-3):143-6
pubmed: 9364518
Brain. 2018 Jan 1;141(1):85-98
pubmed: 29244098
Neurobiol Stress. 2021 Sep 20;15:100398
pubmed: 34646915
Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):41-52
pubmed: 22660922
Circulation. 2002 Dec 3;106(23):2973-9
pubmed: 12460881
Eur Neuropsychopharmacol. 2022 Jan;54:54-61
pubmed: 34773851
Front Aging Neurosci. 2021 Feb 02;13:609679
pubmed: 33603656
CNS Neurosci Ther. 2018 May;24(5):412-419
pubmed: 29316271
Neurosci Lett. 2008 Feb 20;432(2):137-40
pubmed: 18191027
Cell. 2019 Mar 21;177(1):162-183
pubmed: 30901538
J Neurochem. 2005 Apr;93(2):412-21
pubmed: 15816864
Mol Neurodegener. 2011 Nov 25;6:81
pubmed: 22118545
Neuropsychobiology. 2021;80(3):214-224
pubmed: 32726779
Elife. 2019 Aug 13;8:
pubmed: 31407664
Clin Ther. 2000 Nov;22(11):1319-30
pubmed: 11117656
Biol Psychiatry. 2007 Sep 1;62(5):496-504
pubmed: 17585885
J Psychiatr Res. 2008 Jan;42(1):78-82
pubmed: 17113598
Iran J Basic Med Sci. 2015 Mar;18(3):240-6
pubmed: 25945236
Nat Commun. 2020 Aug 13;11(1):4071
pubmed: 32792491
Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
pubmed: 11074872
J Affect Disord. 2014 Aug;165:59-63
pubmed: 24882178
Brain Res. 2017 May 1;1662:65-74
pubmed: 28257780
Neurochem Res. 2021 Apr;46(4):732-739
pubmed: 33521906
Lancet Neurol. 2011 Feb;10(2):187-98
pubmed: 21147038
Annu Rev Immunol. 2017 Apr 26;35:441-468
pubmed: 28226226
Nat Commun. 2020 Jan 9;11(1):131
pubmed: 31919423
Eur J Neurosci. 2006 May;23(10):2611-22
pubmed: 16817864
Eur J Neurosci. 2000 Oct;12(10):3567-74
pubmed: 11029626
Pharmacopsychiatry. 1999 Mar;32 Suppl 1:33-7
pubmed: 10338106
Mol Psychiatry. 2016 Aug;21(8):1009-26
pubmed: 27271499
Cell Mol Neurobiol. 2004 Feb;24(1):123-8
pubmed: 15049516
Cells. 2021 Oct 28;10(11):
pubmed: 34831161
J Biol Chem. 2007 Jun 22;282(25):18057-18068
pubmed: 17485418
J Neurosci Res. 2003 Jan 15;71(2):246-55
pubmed: 12503087
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Neuropharmacology. 2021 Mar 15;186:108474
pubmed: 33524408
Turk Neurosurg. 2020;30(6):871-884
pubmed: 32705669
Schizophr Res. 2004 Apr 1;67(2-3):269-75
pubmed: 14984887
J Neurochem. 2000 Dec;75(6):2259-69
pubmed: 11080177
Int J Mol Sci. 2020 Oct 13;21(20):
pubmed: 33066042
Br J Pharmacol. 1995 Dec;116(8):3227-30
pubmed: 8719800
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):751-6
pubmed: 21177428
Biol Psychiatry. 2001 May 1;49(9):741-52
pubmed: 11331082
Neurobiol Dis. 2010 May;38(2):259-65
pubmed: 20117210
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2052-7
pubmed: 18250315
Mol Psychiatry. 2017 Feb;22(2):296-305
pubmed: 27021815
J Neuroimmune Pharmacol. 2013 Mar;8(1):227-37
pubmed: 22527636
IUBMB Life. 2018 Apr;70(4):336-343
pubmed: 29542225
Acta Neuropathol. 2011 Nov;122(5):615-26
pubmed: 21968533
J Neuroinflammation. 2015 Sep 30;12:184
pubmed: 26419927
Psychother Psychosom. 2016;85(3):129-35
pubmed: 27043036
Biol Psychiatry. 1999 Feb 15;45(4):395-402
pubmed: 10071707
Nature. 2022 Nov;611(7937):769-779
pubmed: 36385529
Neuroscience. 2019 Nov 21;421:152-161
pubmed: 31682950
Brain Res. 2017 Dec 1;1676:83-90
pubmed: 28912059
Neuropharmacology. 2019 May 15;150:175-183
pubmed: 30794835
Pharmacol Biochem Behav. 2015 Mar;130:15-21
pubmed: 25553822
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S213-7
pubmed: 22166439
Biol Psychiatry. 2007 Oct 15;62(8):884-93
pubmed: 17698040
Eur Neuropsychopharmacol. 2020 Feb;31:16-32
pubmed: 31837914
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5063-8
pubmed: 21383152
Free Radic Biol Med. 2014 Aug;73:278-90
pubmed: 24882422
Cell Stem Cell. 2022 Aug 4;29(8):1197-1212.e8
pubmed: 35931030
Exp Neurol. 2020 Jul;329:113312
pubmed: 32294470
Front Psychiatry. 2017 Nov 16;8:238
pubmed: 29201010
Bipolar Disord. 2021 Mar;23(2):130-140
pubmed: 32583570
Neurobiol Learn Mem. 2015 May;121:20-9
pubmed: 25838119
Mult Scler Relat Disord. 2014 Jul;3(4):494-504
pubmed: 25877062
Neurobiol Dis. 2015 Apr;76:57-66
pubmed: 25680941
J Neurosci. 1989 Nov;9(11):3720-7
pubmed: 2585051
FASEB J. 2002 Aug;16(10):1328-30
pubmed: 12154010
Neuron. 2018 Aug 22;99(4):689-701.e5
pubmed: 30078577
Neuroscience. 2008 Jul 17;154(4):1458-66
pubmed: 18555616
J Neurosci. 2009 Jul 29;29(30):9458-70
pubmed: 19641109
Sci China C Life Sci. 1996 Oct;39(5):517-22
pubmed: 9772354
Nature. 2018 Nov;563(7729):72-78
pubmed: 30382198
Ann Neurol. 2004 Nov;56(5):675-88
pubmed: 15468085
Science. 2003 Aug 8;301(5634):805-9
pubmed: 12907793
Stroke. 2009 Feb;40(2):652-5
pubmed: 18974377
Mol Psychiatry. 2018 Mar;23(3):666-673
pubmed: 28439101
Neuropharmacology. 2011 May;60(6):963-74
pubmed: 21288472
FEBS Lett. 2000 Jun 30;476(1-2):55-7
pubmed: 10878250
Neurosci Bull. 2015 Oct;31(5):617-25
pubmed: 26253956
Annu Rev Physiol. 2010;72:335-55
pubmed: 20148679
J Affect Disord. 2018 Dec 1;241:505-513
pubmed: 30149339
Eur J Pharm Sci. 2017 Jan 1;96:72-83
pubmed: 27634580
Transl Psychiatry. 2020 Mar 9;10(1):88
pubmed: 32152295
Front Cell Neurosci. 2018 Nov 13;12:412
pubmed: 30483062
Atherosclerosis. 2001 Sep;158(1):113-9
pubmed: 11500181
Neuropsychiatr Dis Treat. 2015 Feb 26;11:507-16
pubmed: 25750531
Biol Psychiatry. 2015 Apr 15;77(8):711-9
pubmed: 25022604
Eur J Neurosci. 2006 Mar;23(6):1665-70
pubmed: 16553631
Glia. 2006 Jun;53(8):809-16
pubmed: 16541436
Front Cell Neurosci. 2019 Oct 17;13:467
pubmed: 31680875
Biol Psychiatry. 2001 Sep 15;50(6):395-406
pubmed: 11566156
Brain Res. 2002 Dec 27;958(2):305-11
pubmed: 12470866
Neurosci Lett. 2019 Mar 23;696:179-183
pubmed: 30586637
Biol Res. 2005;38(4):381-7
pubmed: 16579521
CNS Drug Rev. 2005 Summer;11(2):169-82
pubmed: 16007238
J Affect Disord. 2016 Apr;194:135-43
pubmed: 26826533
Neuroscience. 2015 May 21;294:60-8
pubmed: 25711936
Hum Mol Genet. 2016 Dec 1;25(23):5126-5141
pubmed: 27655403
Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):e195-e207
pubmed: 31315437
J Pharmacol Sci. 2019 Jun;140(2):120-127
pubmed: 31255518
Front Mol Neurosci. 2018 Aug 28;11:297
pubmed: 30210290
Eur Neuropsychopharmacol. 2012 May;22(5):330-8
pubmed: 21962915
Brain Res. 1992 Dec 11;598(1-2):196-202
pubmed: 1486480
Drug Deliv. 2018 Nov;25(1):43-48
pubmed: 29226728
J Psychiatry Neurosci. 2007 May;32(3):203-10
pubmed: 17476367
Mol Psychiatry. 2000 Nov;5(6):654-63, 571
pubmed: 11126396
Neuropharmacology. 2012 Aug;63(2):274-9
pubmed: 22507665
Cell Mol Neurobiol. 2008 Jun;28(4):613-27
pubmed: 17710536
Biol Psychiatry. 2019 May 15;85(10):850-862
pubmed: 30819514
Cell Calcium. 2005 Sep-Oct;38(3-4):417-25
pubmed: 16095689
Sci Rep. 2017 Apr 18;7:46548
pubmed: 28418035
J Neuroinflammation. 2014 Aug 14;11:140
pubmed: 25115727